SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Chromatics Color Sciences International. Inc; CCSI
CCSI 23.10-1.1%Dec 19 4:00 PM EST
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Gurupup who wrote (1045)2/17/1998 1:50:00 PM
From: David S.  Read Replies (1) of 5736
 
Contacts at CCSI have confirmed to an associate that they will file with the FDA for an additional indication this spring. It also looks like a pretty fast FDA approval process. The color matching process of the colormate can determine the change in skin color upon, and after, death. The device will be used as the final arbiter to determine whether people are in fact, dead. bulls on the stock have reported to me that this additional use will generate royalty revenues of $25 million per year for the next 17 years. the tendency of people to become more pale upon death has been well known for ages, but this is the first device to actually make use of the process. Apparantly, death is the 6th chromogenic disease.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News